1097 related articles for article (PubMed ID: 30306351)
41. Gender dysphoria in children and adolescents: an overview.
Skordis N; Kyriakou A; Dror S; Mushailov A; Nicolaides NC
Hormones (Athens); 2020 Sep; 19(3):267-276. PubMed ID: 32020566
[TBL] [Abstract][Full Text] [Related]
42. Body Image and Sexual Desire in the Context of Gender Affirming Therapy: Results of a Cross-sectional Multi-centered Transgender Study.
Garz M; Schröder J; Nieder T; Becker I; Biedermann S; Hildebrandt T; Briken P; Auer M; Fuß J
J Sex Marital Ther; 2021; 47(5):435-445. PubMed ID: 33616008
[TBL] [Abstract][Full Text] [Related]
43. A National Survey of United States-Based Endocrinologists Who Prescribe Gender-Affirming Hormone Therapy.
Bisno DI; Lubitz S; Marshall I; Cohen DA
Endocr Pract; 2023 Jun; 29(6):465-470. PubMed ID: 36906069
[TBL] [Abstract][Full Text] [Related]
44. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
45. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
46. Gender-Affirming Pharmacological Interventions for Youth With Gender Dysphoria: When Treatment Guidelines Are Not Enough.
Nahata L; Chelvakumar G; Leibowitz S
Ann Pharmacother; 2017 Nov; 51(11):1023-1032. PubMed ID: 28660776
[TBL] [Abstract][Full Text] [Related]
47. Baseline Mental Health and Psychosocial Functioning of Transgender Adolescents Seeking Gender-Affirming Hormone Therapy.
Kuper LE; Mathews S; Lau M
J Dev Behav Pediatr; 2019; 40(8):589-596. PubMed ID: 31166250
[TBL] [Abstract][Full Text] [Related]
48. Gender Dysphoria and Co-Existing Psychosis: Review and Four Case Examples of Successful Gender Affirmative Treatment.
Meijer JH; Eeckhout GM; van Vlerken RH; de Vries AL
LGBT Health; 2017 Apr; 4(2):106-114. PubMed ID: 28170299
[TBL] [Abstract][Full Text] [Related]
49. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
50. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
51. How does gender-affirming hormone therapy affect QOL in transgender patients?
Wilhelm S; Kelsberg G; Safranek S
J Fam Pract; 2022 Dec; 71(10):442-444. PubMed ID: 36735947
[TBL] [Abstract][Full Text] [Related]
52. Understanding Pediatric Patients Who Discontinue Gender-Affirming Hormonal Interventions.
Turban JL; Carswell J; Keuroghlian AS
JAMA Pediatr; 2018 Oct; 172(10):903-904. PubMed ID: 30178056
[No Abstract] [Full Text] [Related]
53. Gender-affirming hormones and surgery in transgender children and adolescents.
Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
[TBL] [Abstract][Full Text] [Related]
54. Sexual Self-Concept Discrepancies Mediate the Relation between Gender Dysphoria Sexual Esteem and Sexual Attitudes in Binary Transgender Individuals.
Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
J Sex Res; 2022 May; 59(4):524-536. PubMed ID: 34279141
[TBL] [Abstract][Full Text] [Related]
55. Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.
Tordoff DM; Wanta JW; Collin A; Stepney C; Inwards-Breland DJ; Ahrens K
JAMA Netw Open; 2022 Feb; 5(2):e220978. PubMed ID: 35212746
[TBL] [Abstract][Full Text] [Related]
56. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
57. Exploring Health and Transition-Related Needs in Polish Transgender and Non-Binary Individuals.
Koziara K; Mijas ME; Wycisk J; Pliczko MP; Grabski B
J Sex Med; 2021 Jun; 18(6):1110-1121. PubMed ID: 34108108
[TBL] [Abstract][Full Text] [Related]
58. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
[TBL] [Abstract][Full Text] [Related]
60. Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study.
Castellini G; Rossi E; Cassioli E; Sanfilippo G; Ristori J; Vignozzi L; Maggi M; Ricca V; Fisher AD
J Sex Med; 2023 Feb; 20(3):388-397. PubMed ID: 36763949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
